These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 27766386)

  • 21. Intranasal delivery of nanomicelle curcumin promotes corneal epithelial wound healing in streptozotocin-induced diabetic mice.
    Guo C; Li M; Qi X; Lin G; Cui F; Li F; Wu X
    Sci Rep; 2016 Jul; 6():29753. PubMed ID: 27405815
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Current and experimental treatment approaches for neurotrophic keratopathy].
    Alder J; Mertsch S; Menzel-Severing J; Geerling G
    Ophthalmologe; 2019 Feb; 116(2):127-137. PubMed ID: 30707284
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical picture and diagnosis of neurotrophic keratopathy].
    Messmer EM
    Ophthalmologe; 2019 Feb; 116(2):120-126. PubMed ID: 30535856
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Variable ptosis after botulinum toxin type a injection with positive ice test mimicking ocular myasthenia gravis.
    Alaraj AM; Oystreck DT; Bosley TM
    J Neuroophthalmol; 2013 Jun; 33(2):169-71. PubMed ID: 23681240
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Botulinum toxin A-induced protective ptosis in corneal disease.
    Kirkness CM; Adams GG; Dilly PN; Lee JP
    Ophthalmology; 1988 Apr; 95(4):473-80. PubMed ID: 3050691
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Botulinum toxin A induced protective ptosis.
    Adams GG; Kirkness CM; Lee JP
    Eye (Lond); 1987; 1 ( Pt 5)():603-8. PubMed ID: 3446541
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurotrophic keratopathy; its pathophysiology and treatment.
    Okada Y; Reinach PS; Kitano A; Shirai K; Kao WW; Saika S
    Histol Histopathol; 2010 Jun; 25(6):771-80. PubMed ID: 20376784
    [TBL] [Abstract][Full Text] [Related]  

  • 28. How to avoid eyelid ptosis when injecting botulinum toxin into the corrugators.
    Parsa FD
    Plast Reconstr Surg; 2000 Apr; 105(4):1564-5. PubMed ID: 10744251
    [No Abstract]   [Full Text] [Related]  

  • 29. Neurotrophic keratopathy.
    Pushker N; Dada T; Vajpayee RB; Gupta V; Aggrawal T; Titiyal JS
    CLAO J; 2001 Apr; 27(2):100-7. PubMed ID: 11352446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Persistent epithelial defects due to neurotrophic keratopathy treated with a substance p-derived peptide and insulin-like growth factor 1.
    Nishida T; Chikama T; Morishige N; Yanai R; Yamada N; Saito J
    Jpn J Ophthalmol; 2007; 51(6):442-7. PubMed ID: 18158595
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Conservative and surgical treatment of neurotrophic keratopathy].
    Seitz B; Grüterich M; Cursiefen C; Kruse FE
    Ophthalmologe; 2005 Jan; 102(1):15-26. PubMed ID: 15622497
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination of serum eye drops with hydrogel bandage contact lenses in the treatment of persistent epithelial defects.
    Schrader S; Wedel T; Moll R; Geerling G
    Graefes Arch Clin Exp Ophthalmol; 2006 Oct; 244(10):1345-9. PubMed ID: 16544115
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Direct observation of corneal nerve fibres in neurotrophic keratopathy by confocal biomicroscopy.
    Morishige N; Komatsubara T; Chikama T; Nishida T
    Lancet; 1999 Nov; 354(9190):1613-4. PubMed ID: 10560682
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathologic epithelial and anterior corneal nerve morphology in early-stage congenital aniridic keratopathy.
    Edén U; Fagerholm P; Danyali R; Lagali N
    Ophthalmology; 2012 Sep; 119(9):1803-10. PubMed ID: 22512983
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diabetic keratopathy.
    Yeung A; Dwarakanathan S
    Dis Mon; 2021 May; 67(5):101135. PubMed ID: 33551178
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Safety and efficacy of botulinum toxin in hemifacial spasm].
    Mazlout H; Kamoun Gargouri H; Triki W; Kéfi S; Brour J; El Afrit MA; Chéour M; Kraiem A
    J Fr Ophtalmol; 2013 Mar; 36(3):242-6. PubMed ID: 23270989
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the efficacy and safety of botulinum toxin type A to induce temporary ptosis in dogs.
    Bittencourt MK; de Vasconcellos JP; Bittencourt MD; Malagó R; Bacellar M
    J Ocul Pharmacol Ther; 2013 May; 29(4):431-6. PubMed ID: 23323889
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Neurotrophic keratopathy--studies on substance P and the clinical significance of corneal sensation].
    Nishida T; Nakamura M; Konma T; Ofuji K; Nagano K; Tanaka T; Enoki M; Reid TW; Brown SM; Murphy CJ; Mannis MJ
    Nippon Ganka Gakkai Zasshi; 1997 Dec; 101(12):948-74. PubMed ID: 9436358
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Botulinum Toxin Type A Induced Brow Ptosis Reversal Using Bacteriostatic Saline.
    Rullan PP; Rullan JM; McKesey J; Velazquez J; Szeremeta J
    Dermatol Surg; 2024 Jul; 50(7):688-690. PubMed ID: 38518190
    [No Abstract]   [Full Text] [Related]  

  • 40. [The cornea: stasis and dynamics].
    Nishida T
    Nippon Ganka Gakkai Zasshi; 2008 Mar; 112(3):179-212; discussion 213. PubMed ID: 18411711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.